NCT05619237View on ClinicalTrials.gov

Pivotal Study of an Antimicrobial Wound Dressing to Treat Chronic Wounds

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 6, 2022

Primary Completion Date

May 26, 2023

Study Completion Date

May 30, 2023

Conditions
Pressure InjuryVenous Leg UlcerPressure Injury Stage 2Pressure Injury Stage IIIDiabetic Foot UlcerPressure Injury Stage IVLeg Ulcer
Interventions
DEVICE

NanoSALV Catalytic

NanoSALV Catalytic Antimicrobial Wound Dressing Gel is a Health Canada approved medical device for the management of Chronic Wounds.

Trial Locations (4)

T2E 6V7

Carewest Dr. Vernon Fanning Long-Term Care, Calgary

T2R 0X7

Sheldon Chumir Wound Clinic, Calgary

T2V 4J2

Calgary Foot Care Nurses Clinic, Calgary

T5G 0B7

Glenrose Rehabilitation Centre, Edmonton

All Listed Sponsors
collaborator

Alberta Health services

OTHER

collaborator

NanoTess Inc.

UNKNOWN

lead

Chester Ho, MD

OTHER